Altria Fails To Nix FDA Tobacco Committee Members

Law360, New York (April 29, 2010, 6:57 PM EDT) -- The U.S. Food and Drug Administration has denied a request from Altria Group Inc. to disqualify four members from a scientific advisory committee that was set up as part of a law that gave the agency sweeping powers to oversee the manufacturing, marketing and sale of tobacco products.

Altria, the parent of Philip Morris USA Inc., voiced concerns that the four committee members had financial and other conflicts of interest, including having worked as paid experts for plaintiffs in litigation.

But in a Wednesday filing with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.